Subtype
Sympathetic Paraganglioma
CI-CAN-00004047Explore in graph →
Non-malignant27 active trials2 evidence items
- NCIt
- C4216
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004047Explore in graph →
Clinical trials
127 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06440122 | The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs) | unknown | — | 100 | King's College Hospital NHS TrustOTHER | 1 | Jun 3, 2024 | clinicaltrials |
| NCT06229405 | Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data | unknown | — | 8,200 | Seoul National University HospitalOTHER | 1 | Mar 4, 2024 |
| clinicaltrials |
| NCT06050057 | Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy | unknown | — | 100 | University Hospital OlomoucOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT06015061 | Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients | unknown | — | 20 | Peking Union Medical College HospitalOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT05158712 | Genetic Factors and Pheochromocytomas in Neoplasia Type 2(NEM2A-Pheo) | unknown | — | 14 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05885399 | The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment | unknown | Phase 2 | 5 | Peking Union Medical College HospitalOTHER | 1 | Jun 2, 2023 | clinicaltrials |
| NCT05885386 | A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL | unknown | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05883085 | A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL | unknown | Phase 2 | 10 | Peking Union Medical College HospitalOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05451134 | Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma | unknown | — | 300 | China National Center for Cardiovascular DiseasesOTHER_GOV | 1 | Jul 12, 2022 | clinicaltrials |
| NCT04890444 | China Adrenal Disease Registry(CASE) | unknown | — | 2,000 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT04891081 | Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease | unknown | — | 50 | University Medical Centre LjubljanaOTHER | 1 | May 18, 2021 | clinicaltrials |
| NCT00874614 | A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma | unknown | Phase 2 | 74 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 20, 2020 | clinicaltrials |
| NCT03158870 | Surgeon-Anesthesiologist Collaboration(CCAP) | unknown | — | 1,122 | Hospices Civils de LyonOTHER | 1 | May 18, 2017 | clinicaltrials |
| NCT01373736 | 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors | unknown | Phase 3 | — | Vancouver Coastal HealthOTHER_GOV | 1 | Jun 15, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Jun 3, 2024source: clinicaltrials